Opportunities lie in the launch of advanced autoinjectors with smart technology and favorable regulatory environments, ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...

Drugmakers have said they’re still unclear about whether Trump will impose tariffs on finished products or on active ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

European firms with high US exposure face mounting risks from tariffs, recession fears, and a weakening dollar, while ...

Pharma trade lobby EFPIA, whose members include European pharma giants Bayer, Novartis and Novo Nordisk, said it had called ...

Novo Nordisk (NVO), the company behind Ozempic and Wegovy, announced that it will invest 6.4 billion reais (about $1.09 ...

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...

The Hashgraph Group (THG), a Swiss-based global business, venture capital, and technology firm dedicated to the Hedera ...

Big Pharma has aimed some choice words at European countries in recent weeks, including calling the UK “uninvestable” and ...